Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cell-Free DNA: Potential Application in COVID-19 Diagnostics and Management
Robert Stawski, Dariusz Nowak, Ewelina Perdas
Viruses (2022) Vol. 14, Iss. 2, pp. 321-321
Open Access | Times Cited: 13

Showing 13 citing articles:

Bridging biological cfDNA features and machine learning approaches
Tina Moser, Stefan Kühberger, Isaac Lazzeri, et al.
Trends in Genetics (2023) Vol. 39, Iss. 4, pp. 285-307
Open Access | Times Cited: 64
Battle of the Biomarkers of Systemic Inflammation
Emilia Stec‐Martyna, Karolina Wojtczak, Dariusz Nowak, et al.
Biology (2025) Vol. 14, Iss. 4, pp. 438-438
Open Access
Anti-cardiolipin IgG autoantibodies associate with circulating extracellular DNA in severe COVID-19
Daniel Bertin, Alexandre Brodovitch, Alexandre Lopez, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 16
Cellular pathways and molecular events that shape autoantibody production in COVID-19
Gregory J. Tsay, Moncef Zouali
Journal of Autoimmunity (2024) Vol. 147, pp. 103276-103276
Closed Access | Times Cited: 3
Increased levels of circulating cell-free DNA in COVID-19 patients with respiratory failure
Akihiko Tanaka, Katsuki Wakayama, Y Fukuda, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Plasma cfDNA predictors of established bacteraemic infection
Nadia Urosevic, Adam J. Merritt, Timothy J. J. Inglis
Access Microbiology (2022) Vol. 4, Iss. 6
Open Access | Times Cited: 9
Using Precision Medicine for the Diagnosis and Treatment of Viral Pneumonia
Richard Watkins
Advances in Therapy (2022) Vol. 39, Iss. 7, pp. 3061-3071
Open Access | Times Cited: 8
The Diagnostic, Prognostic, and Therapeutic Potential of Cell-Free DNA with a Special Focus on COVID-19 and Other Viral Infections
Galina Hovhannisyan, Tigran Harutyunyan, Rouben Aroutiounian, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14163-14163
Open Access | Times Cited: 4
Cell free DNA as a new prognostic biomarker for COVID-19, A prospective cohort study
Hazal Erdem, İ̇lker İnanç Balkan, Rıdvan Karaali, et al.
Diagnostic Microbiology and Infectious Disease (2024) Vol. 110, Iss. 1, pp. 116367-116367
Closed Access | Times Cited: 1
Utility of Monocyte Expression of HLA-DR versus T Lymphocyte Frequency in the Assessment of COVID-19 Outcome
Reham Hammad, Hend G. Kotb, Gehan Abdel-Rahman Eldesoky, et al.
International Journal of General Medicine (2022) Vol. Volume 15, pp. 5073-5087
Open Access | Times Cited: 7
Human Identical Sequences, hyaluronan, and hymecromone ─ the new mechanism and management of COVID-19
Shuai Yang, Ying Tong, Lu Chen, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 7
Integrating plasma cell‐free DNA with clinical laboratory results enhances the prediction of critically ill patients with COVID‐19 at hospital admission
Yong Bai, Fang Zheng, Tongda Zhang, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 7
Open Access | Times Cited: 6
Cell Free DNA as a New Prognostic Biomarker for Covid-19, a Prospective Cohort Study
Hazal Erdem, İ̇lker İnanç Balkan, Rıdvan Karaali, et al.
(2024)
Closed Access
CRISPR /Cas System
Deepak Kumar Sahel, Mohd Azhar
(2023), pp. 101-127
Closed Access
Page 1

Scroll to top